Removal of APIs and bacteria from hospital wastewater by MBR plus O-3, O-3 + H2O2, PAC or ClO2
(2013) In Water Science and Technology 67(4). p.854-862- Abstract
 - The objective of this study has been to develop technologies that can reduce the content of active pharmaceutical ingredients (APIs) and bacteria from hospital wastewater. The results from the laboratory-and pilot-scale testings showed that efficient removal of the vast majority of APIs could be achieved by a membrane bioreactor (MBR) followed by ozone, ozone + hydrogen peroxide or powdered activated carbon (PAC). Chlorine dioxide (ClO2) was significantly less effective. MBR + PAC (450 mg/l) was the most efficient technology, while the most cost-efficient technology was MBR + ozone (156 mg O-3/l applied over 20 min). With MBR an efficient removal of Escherichia coli and enterococci was measured, and no antibiotic resistant bacteria were... (More)
 - The objective of this study has been to develop technologies that can reduce the content of active pharmaceutical ingredients (APIs) and bacteria from hospital wastewater. The results from the laboratory-and pilot-scale testings showed that efficient removal of the vast majority of APIs could be achieved by a membrane bioreactor (MBR) followed by ozone, ozone + hydrogen peroxide or powdered activated carbon (PAC). Chlorine dioxide (ClO2) was significantly less effective. MBR + PAC (450 mg/l) was the most efficient technology, while the most cost-efficient technology was MBR + ozone (156 mg O-3/l applied over 20 min). With MBR an efficient removal of Escherichia coli and enterococci was measured, and no antibiotic resistant bacteria were detected in the effluent. With MBR + ozone and MBR + PAC also the measured effluent concentrations of APIs (e.g. ciprofloxacin, sulfamethoxazole and sulfamethizole) were below available predicted no-effect concentrations (PNEC) for the marine environment without dilution. Iodinated contrast media were also reduced significantly (80-99% for iohexol, iopromide and ioversol and 40-99% for amidotrizoateacid). A full-scale MBR treatment plant with ozone at a hospital with 900 beds is estimated to require an investment cost of (sic)1.6 mill. and an operating cost of (sic)1/m(3) of treated water. (Less)
 
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/3671405
- author
 - Nielsen, U. ; Hastrup, C. ; Klausen, M. M. ; Pedersen, B. M. ; Kristensen, G. H. ; la Cour Jansen, Jes LU ; Bak, S. N. and Tuerk, J.
 - organization
 - publishing date
 - 2013
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - keywords
 - Advanced oxidation processes, bacteria, hospital wastewater, MBR, pharmaceuticals
 - in
 - Water Science and Technology
 - volume
 - 67
 - issue
 - 4
 - pages
 - 854 - 862
 - publisher
 - IWA Publishing
 - external identifiers
 - 
                
- wos:000315194900021
 - scopus:84874927702
 - pmid:23306265
 
 - ISSN
 - 0273-1223
 - DOI
 - 10.2166/wst.2012.645
 - language
 - English
 - LU publication?
 - yes
 - id
 - 8d6a2e8c-0a32-4f95-b36f-ade49ff0a49c (old id 3671405)
 - date added to LUP
 - 2016-04-01 14:04:18
 - date last changed
 - 2025-10-14 11:16:39
 
@article{8d6a2e8c-0a32-4f95-b36f-ade49ff0a49c,
  abstract     = {{The objective of this study has been to develop technologies that can reduce the content of active pharmaceutical ingredients (APIs) and bacteria from hospital wastewater. The results from the laboratory-and pilot-scale testings showed that efficient removal of the vast majority of APIs could be achieved by a membrane bioreactor (MBR) followed by ozone, ozone + hydrogen peroxide or powdered activated carbon (PAC). Chlorine dioxide (ClO2) was significantly less effective. MBR + PAC (450 mg/l) was the most efficient technology, while the most cost-efficient technology was MBR + ozone (156 mg O-3/l applied over 20 min). With MBR an efficient removal of Escherichia coli and enterococci was measured, and no antibiotic resistant bacteria were detected in the effluent. With MBR + ozone and MBR + PAC also the measured effluent concentrations of APIs (e.g. ciprofloxacin, sulfamethoxazole and sulfamethizole) were below available predicted no-effect concentrations (PNEC) for the marine environment without dilution. Iodinated contrast media were also reduced significantly (80-99% for iohexol, iopromide and ioversol and 40-99% for amidotrizoateacid). A full-scale MBR treatment plant with ozone at a hospital with 900 beds is estimated to require an investment cost of (sic)1.6 mill. and an operating cost of (sic)1/m(3) of treated water.}},
  author       = {{Nielsen, U. and Hastrup, C. and Klausen, M. M. and Pedersen, B. M. and Kristensen, G. H. and la Cour Jansen, Jes and Bak, S. N. and Tuerk, J.}},
  issn         = {{0273-1223}},
  keywords     = {{Advanced oxidation processes; bacteria; hospital wastewater; MBR; pharmaceuticals}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{854--862}},
  publisher    = {{IWA Publishing}},
  series       = {{Water Science and Technology}},
  title        = {{Removal of APIs and bacteria from hospital wastewater by MBR plus O-3, O-3 + H2O2, PAC or ClO2}},
  url          = {{http://dx.doi.org/10.2166/wst.2012.645}},
  doi          = {{10.2166/wst.2012.645}},
  volume       = {{67}},
  year         = {{2013}},
}